Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

[Amyloid β-related angiitis presenting extensive brain involvement without detection of hemorrhagic lesions: A case report].

Hatano Y, Sugai A, Yamagishi T, Nakajima A, Kakita A, Onodera O.

Rinsho Shinkeigaku. 2020 Feb 26. doi: 10.5692/clinicalneurol.cn-001340. [Epub ahead of print] Japanese.

PMID:
32101841
2.

Hemorrhagic cerebral small vessel disease caused by a novel mutation in 3' UTR of collagen type IV alpha 1.

Sakai N, Uemura M, Kato T, Nozaki H, Koyama A, Ando S, Kamei H, Kato M, Onodera O.

Neurol Genet. 2019 Dec 26;6(1):e383. doi: 10.1212/NXG.0000000000000383. eCollection 2020 Feb. No abstract available.

3.

Refractory Myositis Affecting the Intrinsic Muscles of the Hand: A Case Report.

Nakamura K, Sugai A, Saji E, Kasuga K, Onodera O.

Intern Med. 2020 Jan 17. doi: 10.2169/internalmedicine.3773-19. [Epub ahead of print]

4.

[Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions].

Kasahara S, Ishihara T, Koike Y, Sugai A, Onodera O.

Rinsho Shinkeigaku. 2020 Feb 27;60(2):109-116. doi: 10.5692/clinicalneurol.cn-001362. Epub 2020 Jan 19. Japanese.

PMID:
31956195
5.

Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials.

Nishizawa M, Onodera O, Hirakawa A, Shimizu Y, Yamada M; Rovatirelin Study Group.

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):254-262. doi: 10.1136/jnnp-2019-322168. Epub 2020 Jan 14.

6.

Publisher Correction: A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation.

Hatakeyama M, Kanazawa M, Ninomiya I, Omae K, Kimura Y, Takahashi T, Onodera O, Fukushima M, Shimohata T.

Sci Rep. 2019 Dec 20;9(1):19913. doi: 10.1038/s41598-019-55308-2.

7.

Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia.

Ando S, Kanazawa M, Onodera O.

J Mov Disord. 2020 Jan;13(1):20-26. doi: 10.14802/jmd.19061. Epub 2019 Dec 19.

8.

Amyotrophic Lateral Sclerosis with Pallidonigroluysian Degeneration: A Clinicopathological Study.

Ito J, Shimizu H, Ohta K, Idezuka J, Tanaka H, Kondo H, Nakajima T, Takahashi H, Akazawa K, Onodera O, Kakita A.

Ann Neurol. 2020 Feb;87(2):302-312. doi: 10.1002/ana.25652. Epub 2019 Dec 10.

PMID:
31773773
9.

Role of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinib.

Uemura M, Kanazawa M, Yamagishi T, Nagai T, Takahashi M, Koide S, Tada M, Shimbo J, Isami A, Makino K, Masuko M, Nikkuni K, Okamoto K, Igarashi S, Morita K, Onodera O.

J Neurol Sci. 2020 Jan 15;408:116577. doi: 10.1016/j.jns.2019.116577. Epub 2019 Nov 9. No abstract available.

PMID:
31733606
10.

A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation.

Hatakeyama M, Kanazawa M, Ninomiya I, Omae K, Kimura Y, Takahashi T, Onodera O, Fukushima M, Shimohata T.

Sci Rep. 2019 Nov 14;9(1):16819. doi: 10.1038/s41598-019-53418-5. Erratum in: Sci Rep. 2019 Dec 20;9(1):19913.

11.

[Molecular Pathogenesis of Amyotrophic Lateral Sclerosis].

Tsuboguchi S, Ishihara T, Sugai A, Yokoseki A, Onodera O.

Brain Nerve. 2019 Nov;71(11):1183-1189. doi: 10.11477/mf.1416201428. Japanese.

PMID:
31722304
12.

HTRA1 Disorder.

Onodera O, Nozaki H, Fukutake T.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2010 Apr 27 [updated 2019 Nov 7].

13.

Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.

Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, Tomiyama M, Ishihara T, Onodera O, Kakita A, Wakabayashi K.

Acta Neuropathol Commun. 2019 Oct 28;7(1):165. doi: 10.1186/s40478-019-0824-1.

14.

Morphological characterisation of glial and neuronal tau pathology in globular glial tauopathy (Types II and III).

Tanaka H, Toyoshima Y, Kawakatsu S, Kobayashi R, Yokota O, Terada S, Kuroda S, Miura T, Higuchi Y, Otsu H, Sanpei K, Otani K, Ikeuchi T, Onodera O, Kakita A, Takahashi H.

Neuropathol Appl Neurobiol. 2019 Oct 10. doi: 10.1111/nan.12581. [Epub ahead of print]

PMID:
31600825
15.

Spinocerebellar Ataxia Type 17.

Toyoshima Y, Onodera O, Yamada M, Tsuji S, Takahashi H.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
2005 Mar 29 [updated 2019 Sep 12].

16.

Shrinkage of the myenteric neurons of the small intestine in patients with multiple system atrophy.

Ozawa T, Shimizu H, Matsui H, Onodera O, Kakita A.

Auton Neurosci. 2019 Nov;221:102583. doi: 10.1016/j.autneu.2019.102583. Epub 2019 Aug 22.

PMID:
31476714
17.

HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade.

Uemura M, Nozaki H, Koyama A, Sakai N, Ando S, Kanazawa M, Kato T, Onodera O.

Front Neurol. 2019 Jun 28;10:693. doi: 10.3389/fneur.2019.00693. eCollection 2019.

18.

Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation.

Sugai A, Kato T, Koyama A, Koike Y, Konno T, Ishihara T, Onodera O.

Neurobiol Dis. 2019 Oct;130:104534. doi: 10.1016/j.nbd.2019.104534. Epub 2019 Jul 13.

PMID:
31310801
19.

Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Kubo A, Ueda S, Yamane A, Wada-Kakuda S, Narita M, Matsuyama M, Nomori A, Takashima A, Kato T, Onodera O, Goto M, Ito M, Tomiyama T, Mori H, Murayama S, Ihara Y, Misonou H, Miyasaka T.

J Neurosci. 2019 Aug 21;39(34):6781-6797. doi: 10.1523/JNEUROSCI.2845-18.2019. Epub 2019 Jun 24.

20.

Is the population of Sado Island genetically close to the population of western Japan?

Misawa K, Watanabe H, Yokoseki A, Wakasugi M, Onodera O, Narita I, Momotsu T, Sato K, Endo N.

Hum Genome Var. 2019 Jun 4;6:26. doi: 10.1038/s41439-019-0058-6. eCollection 2019.

21.

Angiogenesis in the ischemic core: A potential treatment target?

Kanazawa M, Takahashi T, Ishikawa M, Onodera O, Shimohata T, Del Zoppo GJ.

J Cereb Blood Flow Metab. 2019 May;39(5):753-769. doi: 10.1177/0271678X19834158. Epub 2019 Mar 6.

PMID:
30841779
22.

Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy.

Mezaki N, Miura T, Ogaki K, Eriguchi M, Mizuno Y, Komatsu K, Yamazaki H, Suetsugi N, Kawajiri S, Yamasaki R, Ishiguro T, Konno T, Nozaki H, Kasuga K, Okuma Y, Kira JI, Hara H, Onodera O, Ikeuchi T.

Neurol Genet. 2018 Dec 7;4(6):e292. doi: 10.1212/NXG.0000000000000292. eCollection 2018 Dec.

23.

Globular glial tauopathy Type II: Clinicopathological study of two autopsy cases.

Tanaka H, Kawakatsu S, Toyoshima Y, Miura T, Mezaki N, Mano A, Sanpei K, Kobayashi R, Hayashi H, Otani K, Ikeuchi T, Onodera O, Kakita A, Takahashi H.

Neuropathology. 2019 Apr;39(2):111-119. doi: 10.1111/neup.12532. Epub 2019 Jan 15.

PMID:
30646429
24.

Retinal Vasculopathy With Cerebral Leukodystrophy: Clinicopathologic Features of an Autopsied Patient With a Heterozygous TREX 1 Mutation.

Saito R, Nozaki H, Kato T, Toyoshima Y, Tanaka H, Tsubata Y, Morioka T, Horikawa Y, Oyanagi K, Morita T, Onodera O, Kakita A.

J Neuropathol Exp Neurol. 2019 Feb 1;78(2):181-186. doi: 10.1093/jnen/nly115.

PMID:
30561700
25.

Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy.

Kato K, Maemura R, Wakamatsu M, Yamamori A, Hamada M, Kataoka S, Narita A, Miwata S, Sekiya Y, Kawashima N, Suzuki K, Narita K, Doisaki S, Muramatsu H, Sakaguchi H, Matsumoto K, Koike Y, Onodera O, Kaga M, Shimozawa N, Yoshida N.

Mol Genet Metab Rep. 2018 Nov 20;18:1-6. doi: 10.1016/j.ymgmr.2018.11.001. eCollection 2019 Mar.

26.

Clinicopathologic Features of Two Patients With Sporadic Amyotrophic Lateral Sclerosis Who Maintained Communication Ability for Over 30 Years.

Ito J, Shimada T, Tada M, Shimizu H, Wakabayashi M, Yokoseki A, Onodera O, Takahashi H, Kakita A.

J Neuropathol Exp Neurol. 2018 Nov 1;77(11):981-986. doi: 10.1093/jnen/nly082.

PMID:
30239892
27.

Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

Miura T, Mezaki N, Konno T, Iwasaki A, Hara N, Miura M, Funayama M, Unai Y, Tashiro Y, Okita K, Kihara T, Ito N, Kanatsuka Y, Jones DT, Hara N, Ishiguro T, Tokutake T, Kasuga K, Nozaki H, Dickson DW, Onodera O, Wszolek ZK, Ikeuchi T.

J Neurol. 2018 Oct;265(10):2415-2424. doi: 10.1007/s00415-018-9017-2. Epub 2018 Aug 22.

28.

Low serum 25-hydroxyvitamin D increases cognitive impairment in elderly people.

Sakuma M, Kitamura K, Endo N, Ikeuchi T, Yokoseki A, Onodera O, Oinuma T, Momotsu T, Sato K, Nakamura K, Narita I.

J Bone Miner Metab. 2019 Mar;37(2):368-375. doi: 10.1007/s00774-018-0934-z. Epub 2018 Jun 14.

PMID:
29948345
29.

CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.

Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E, Hamade Y, Onodera O, Matsuoka M, Shimizu H, Iwata H, Abe R.

J Am Acad Dermatol. 2018 Dec;79(6):1039-1046. doi: 10.1016/j.jaad.2018.06.025. Epub 2018 Jun 19.

PMID:
29928911
30.

Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation.

Ito J, Nozaki H, Toyoshima Y, Abe T, Sato A, Hashidate H, Igarashi S, Onodera O, Takahashi H, Kakita A.

Neuropathology. 2018 May 25. doi: 10.1111/neup.12473. [Epub ahead of print]

PMID:
29797751
31.

Predictors of cognitive impairment in multiple system atrophy.

Hatakeyama M, Sato T, Takahashi T, Kanazawa M, Onodera O, Nishizawa M, Shimohata T.

J Neurol Sci. 2018 May 15;388:128-132. doi: 10.1016/j.jns.2018.03.017. Epub 2018 Mar 10.

PMID:
29627006
32.

Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.

Ishiura H, Doi K, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, Toyoshima Y, Kakita A, Takahashi H, Suzuki Y, Sugano S, Qu W, Ichikawa K, Yurino H, Higasa K, Shibata S, Mitsue A, Tanaka M, Ichikawa Y, Takahashi Y, Date H, Matsukawa T, Kanda J, Nakamoto FK, Higashihara M, Abe K, Koike R, Sasagawa M, Kuroha Y, Hasegawa N, Kanesawa N, Kondo T, Hitomi T, Tada M, Takano H, Saito Y, Sanpei K, Onodera O, Nishizawa M, Nakamura M, Yasuda T, Sakiyama Y, Otsuka M, Ueki A, Kaida KI, Shimizu J, Hanajima R, Hayashi T, Terao Y, Inomata-Terada S, Hamada M, Shirota Y, Kubota A, Ugawa Y, Koh K, Takiyama Y, Ohsawa-Yoshida N, Ishiura S, Yamasaki R, Tamaoka A, Akiyama H, Otsuki T, Sano A, Ikeda A, Goto J, Morishita S, Tsuji S.

Nat Genet. 2018 Apr;50(4):581-590. doi: 10.1038/s41588-018-0067-2. Epub 2018 Mar 5.

PMID:
29507423
33.

Robustness and Vulnerability of the Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for ALS Pathology Based on in Silico Data.

Sugai A, Kato T, Koyama A, Koike Y, Kasahara S, Konno T, Ishihara T, Onodera O.

Front Neurosci. 2018 Feb 1;12:28. doi: 10.3389/fnins.2018.00028. eCollection 2018.

34.

Loss of Motor Neurons Innervating Cervical Muscles in Patients With Multiple System Atrophy and Dropped Head.

Saito R, Tada M, Toyoshima Y, Nishizawa M, Onodera O, Takahashi H, Kakita A.

J Neuropathol Exp Neurol. 2018 Apr 1;77(4):317-324. doi: 10.1093/jnen/nly007.

PMID:
29420736
35.

Case Report: A patient with spinocerebellar ataxia type 31 and sporadic Creutzfeldt-Jakob disease.

Saito N, Ishihara T, Kasuga K, Nishida M, Ishiguro T, Nozaki H, Shimohata T, Onodera O, Nishizawa M.

Prion. 2018 Mar 4;12(2):147-149. doi: 10.1080/19336896.2018.1436926. Epub 2018 Mar 9.

36.

Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis.

Tohnai G, Nakamura R, Sone J, Nakatochi M, Yokoi D, Katsuno M, Watanabe H, Watanabe H, Ito M, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Onodera O, Naruse H, Mitsui J, Takahashi Y, Goto J, Ishiura H, Morishita S, Yoshimura J, Doi K, Tsuji S, Nakashima K, Kaji R, Atsuta N, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS).

Neurobiol Aging. 2018 Apr;64:158.e15-158.e19. doi: 10.1016/j.neurobiolaging.2017.12.005. Epub 2017 Dec 11.

PMID:
29398122
37.

Operation of a P300-based brain-computer interface in patients with Duchenne muscular dystrophy.

Utsumi K, Takano K, Okahara Y, Komori T, Onodera O, Kansaku K.

Sci Rep. 2018 Jan 29;8(1):1753. doi: 10.1038/s41598-018-20125-6.

38.

CARASIL families from India with 3 novel null mutations in the HTRA1 gene.

Preethish-Kumar V, Nozaki H, Tiwari S, Vengalil S, Bhat M, Prasad C, Onodera O, Uemura M, Doniparthi S, Saini J, Nashi S, Polavarapu K, Nalini A.

Neurology. 2017 Dec 5;89(23):2392-2394. doi: 10.1212/WNL.0000000000004710. Epub 2017 Nov 3. No abstract available.

PMID:
29101275
39.

New diagnostic criteria for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukocencephalopathy in Japan.

Mizuta I, Watanabe-Hosomi A, Koizumi T, Mukai M, Hamano A, Tomii Y, Kondo M, Nakagawa M, Tomimoto H, Hirano T, Uchino M, Onodera O, Mizuno T.

J Neurol Sci. 2017 Oct 15;381:62-67. doi: 10.1016/j.jns.2017.08.009. Epub 2017 Aug 8.

40.

Apparent diffusion coefficient reduction might be a predictor of poor outcome in patients with posterior reversible encephalopathy syndrome.

Ninomiya I, Kanazawa M, Akaiwa Y, Shimohata T, Okamoto K, Onodera O, Nishizawa M.

J Neurol Sci. 2017 Oct 15;381:1-3. doi: 10.1016/j.jns.2017.08.002. Epub 2017 Aug 7.

PMID:
28991655
41.

Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation.

Konno T, Yoshida K, Mizuta I, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Onodera O, Wszolek ZK, Ikeuchi T.

Eur J Neurol. 2018 Jan;25(1):142-147. doi: 10.1111/ene.13464. Epub 2017 Oct 19.

42.

[Overview of Hereditary Spinocerebellar Ataxias in Japan].

Tada M, Yokoseki A, Onodera O.

Brain Nerve. 2017 Aug;69(8):879-890. doi: 10.11477/mf.1416200839. Japanese.

PMID:
28819072
43.

A CARASIL Patient from Americas with Novel Mutation and Atypical Features: Case Presentation and Literature Review.

Ibrahimi M, Nozaki H, Lee A, Onodera O, Reichwein R, Wicklund M, El-Ghanem M.

Cerebrovasc Dis. 2017;44(3-4):135-140. doi: 10.1159/000477358. Epub 2017 Jun 21. Review.

PMID:
28628911
44.

The Clinical Features, Risk Factors, and Surgical Treatment of Cervicogenic Headache in Patients With Cervical Spine Disorders Requiring Surgery.

Shimohata K, Hasegawa K, Onodera O, Nishizawa M, Shimohata T.

Headache. 2017 Jul;57(7):1109-1117. doi: 10.1111/head.13123. Epub 2017 Jun 5.

PMID:
28581034
45.

Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.

Shiba-Fukushima K, Ishikawa KI, Inoshita T, Izawa N, Takanashi M, Sato S, Onodera O, Akamatsu W, Okano H, Imai Y, Hattori N.

Hum Mol Genet. 2017 Aug 15;26(16):3172-3185. doi: 10.1093/hmg/ddx201.

PMID:
28541509
46.

Multiple system atrophy: clinicopathological characteristics in Japanese patients.

Ozawa T, Onodera O.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(5):251-258. doi: 10.2183/pjab.93.016. Review.

47.

[PRES: Posterior Reversible Encephalopathy Syndrome].

Okamoto K, Motohashi K, Fujiwara H, Ishihara T, Ninomiya I, Onodera O, Fujii Y.

Brain Nerve. 2017 Feb;69(2):129-141. doi: 10.11477/mf.1416200653. Review. Japanese.

PMID:
28202821
48.

Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats.

Kanazawa M, Miura M, Toriyabe M, Koyama M, Hatakeyama M, Ishikawa M, Nakajima T, Onodera O, Takahashi T, Nishizawa M, Shimohata T.

Sci Rep. 2017 Feb 14;7:42582. doi: 10.1038/srep42582.

49.

[Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)].

Uemura M, Nozaki H, Onodera O.

Brain Nerve. 2017 Jan;69(1):25-33. doi: 10.11477/mf.1416200631. Japanese.

PMID:
28126975
50.

Association between dialysis treatment and cognitive decline: A study from the Project in Sado for Total Health (PROST), Japan.

Watanabe Y, Kitamura K, Nakamura K, Sanpei K, Wakasugi M, Yokoseki A, Kabasawa K, Onodera O, Ikeuchi T, Kuwano R, Momotsu T, Narita I, Endo N.

Geriatr Gerontol Int. 2017 Oct;17(10):1584-1587. doi: 10.1111/ggi.12937. Epub 2016 Nov 21.

PMID:
27869346

Supplemental Content

Loading ...
Support Center